Tilray Medical Expands Its Cannabis Offerings
Tilray Medical, a prominent division of Tilray Brands, Inc. (NASDAQ: TLRY), is making significant strides in the medical cannabis industry. The company has recently announced enhancements to its formidable cannabis extract portfolio in Germany. As a leader in this sector, Tilray is committed to empowering patients and healthcare practitioners to make informed health decisions. The expansion introduces exciting new products designed to address the evolving needs of patients and the preferences of healthcare providers.
New Product Launches to Meet Patient Needs
Recent additions to Tilray’s medical cannabis offerings in Germany include two notable products aimed at meeting the high demand for balanced cannabis extracts. These extracts are favored among practitioners and patients alike for their therapeutic benefits. The new product sizes and formulations are crafted to support various treatment needs while ensuring ease of accessibility.
High-Potency THC50 CBD50 Extract
The Tilray THC50 CBD50 (25ml) extract is a high-potency offering that caters to patients seeking an elevated cannabinoid content. This product uniquely combines THC and CBD in a 1:1 ratio, providing a balanced therapeutic effect that is highly sought after in the market.
Trial Size THC10 CBD10 Extract
In response to patient and physician requests, Tilray has also introduced the THC10 CBD10 (10ml) extract. This trial size product and aims to facilitate easier initial dosing, thus allowing patients to explore their treatment options with greater flexibility and comfort.
Driving Innovation in Medical Cannabis
Denise Faltischek, Chief Strategy Officer and Head of International at Tilray, emphasizes the company's commitment to innovation and education in the field of medical cannabis. She stated that this focus drives their efforts to ensure both patients and healthcare providers trust the safety and efficacy of their products. Tilray Medical consistently evaluates its product offerings in collaboration with healthcare professionals, allowing them to innovatively tailor their portfolio to better serve the diverse needs of patients.
Availability of Medical Cannabis Products
Tilray Medical’s diverse cannabis products are available through pharmacies across Germany, provided patients have a physician's prescription. This accessibility is vital for maintaining a supportive treatment environment for individuals needing therapeutic alternatives.
Product Line Overview
Some key products from Tilray Medical's cannabis extract portfolio include:
- Tilray THC10 CBD10 in 25ml & 10ml sizes
- Tilray THC50 CBD50 (25ml)
- Tilray THC25 CBD25 (25ml)
- Tilray THC25
- Tilray THC5 CBD20
- Tilray THC20 CBD6
About Tilray Medical
Tilray Medical is dedicated to improving the quality of life for patients by providing safe and reliable access to a global portfolio that includes multiple trusted medical cannabis brands. These brands span across various regions, having established a significant presence in Canada, Portugal, and Germany. The commitment to quality care is reflected in their extensive research and development efforts, which aim to expand product offerings and enhance patient well-being worldwide.
About Tilray Brands
Tilray Brands, Inc. (NASDAQ: TLRY) is recognized as a leading global lifestyle and consumer packaged goods company. It operates across multiple regions, including Canada, Europe, the United States, Australia, and New Zealand. With a mission to create transformative experiences, Tilray supports a broad range of brands and innovative products that span the cannabis, beverage, wellness, and entertainment sectors—all designed to bring joy and connection to consumers.
Frequently Asked Questions
What new products has Tilray Medical launched in Germany?
Tilray Medical has introduced the THC50 CBD50 (25ml) and THC10 CBD10 (10ml) extracts as part of its expanded cannabis product portfolio in Germany.
How does Tilray ensure product quality and safety?
Tilray Medical collaborates closely with healthcare providers and continuously evaluates its product offerings to meet safety and efficacy standards, gaining trust among patients and doctors.
Where can patients access Tilray's medical cannabis products?
Patients can access Tilray’s medical cannabis products at pharmacies throughout Germany with a physician’s prescription.
What is the significance of the THC50 CBD50 formulation?
This high-potency product is designed for patients needing a stronger therapeutic effect while maintaining a balanced cannabinoid ratio, which is increasingly popular in the medical cannabis community.
Can patients try smaller product sizes from Tilray?
Yes, Tilray’s THC10 CBD10 is available in a trial size (10ml) to allow patients to explore their treatment options comfortably.
